Sanjiv Lal

Sanjiv Lal is the CEO and Co-Founder of RegenTherapy and Regen Quantum, regenerative biotechnology companies focused on advancing acellular biologics, regenerative signaling, and next-generation longevity therapeutics. He also serves as Co-Founder and Partner of Motivant, a family office and private investment platform that builds, acquires, and scales companies across healthcare, biotechnology, life sciences, diagnostics, and consumer health.

Over the past two decades, Sanjiv has founded, invested in, acquired, and operated multiple healthcare and biotechnology businesses, successfully leading organizations from early-stage development through commercialization and strategic exits. His experience spans pharmaceutical sciences, laboratory operations, regenerative medicine, precision diagnostics, clinical services, and healthcare infrastructure.

As both an operator and allocator of capital, Sanjiv has evaluated and deployed investments across private companies with a focus on technologies capable of transforming human health and longevity. His investment philosophy centers on identifying scalable platforms at the intersection of biology, engineering, and commercialization, while partnering closely with founders to accelerate growth and create long-term enterprise value.

A first-generation American, Sanjiv earned both his Bachelor of Science and Master of Science degrees in Pharmaceutical Sciences from The Ohio State University. He is recognized for bridging scientific innovation with disciplined business execution and has become a respected voice in regenerative medicine, longevity biotechnology, and healthcare entrepreneurship.

Today, Sanjiv is leading the development of one of the industry's most ambitious regenerative signaling platforms, with the goal of making advanced regenerative therapies more scalable, accessible, and impactful worldwide.

BACK